Value of Tissue Doppler Echocardiography in Predicting Response to Cardiac Resynchronization Therapy in Patients With Heart Failure

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1153-1158

  Van Bommel, Rutger J ^a   Ypenburg, Claudia ^a   Borleffs, C Jan Willem ^a   Delgado, Victoria ^a   Marsan, Nina Ajmone ^a   Bertini, Matteo ^a   Holman, Eduard R ^a   Schalij, Martin J ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SURVIVAL RATE; TISSUE DOPPLER IMAGING; TREATMENT RESPONSE; ULTRASOUND TRANSDUCER; VALIDATION STUDY;

AGED; CARDIAC VOLUME; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950370612     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.018     Document Type: Article

References (28)

1. Chung E.S., Leon A.R., Tavazzi L., Sun J.P., Nihoyannopoulos P., Merlino J., Abraham W.T., Ghio S., Leclercq C., Bax J.J., Yu C.M., Gorcsan III J., St John Sutton M., De Sutter J., and Murillo J. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117 (2008) 2608-2616
2. Bax J.J., Marwick T.H., Molhoek S.G., Bleeker G.B., van Erven L., Boersma E., Steendijk P., van der Wall E.E., and Schalij M.J. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol 92 (2003) 1238-1240
3. Bax J.J., Bleeker G.B., Marwick T.H., Molhoek S.G., Boersma E., Steendijk P., van der Wall E.E., and Schalij M.J. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 (2004) 1834-1840
4. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
5. Guyatt G.H., Sullivan M.J., Thompson P.J., Fallen E.L., Pugsley S.O., Taylor D.W., and Berman L.B. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132 (1985) 919-923
6. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., and Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee On Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
7. Bleeker G.B., Schalij M.J., Molhoek S.G., Verwey H.F., Holman E.R., Boersma E., Steendijk P., van der Wall E.E., and Bax J.J. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol 15 (2004) 544-549
8. Gras D., Leclercq C., Tang A.S., Bucknall C., Luttikhuis H.O., and Kirstein-Pedersen A. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 4 (2002) 311-320
9. Bristow M.R., Saxon L.A., Boehmer J., Krueger S., Kass D.A., De Marco T., Carson P., DiCarlo L., DeMets D., White B.G., DeVries D.W., and Feldman A.M. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
10. St John Sutton M.G., Plappert T., Abraham W.T., Smith A.L., DeLurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Fisher W.G., Ellestad M., Messenger J., Kruger K., Hilpisch K.E., and Hill M.R. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 107 (2003) 1985-1990
11. Sutton M.S., and Keane M.G. Reverse remodelling in heart failure with cardiac resynchronisation therapy. Heart 93 (2007) 167-171
12. Vardas P.E., Auricchio A., Blanc J.J., Daubert J.C., Drexler H., Ector H., Gasparini M., Linde C., Morgado F.B., Oto A., Sutton R., and Trusz-Gluza M. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28 (2007) 2256-2295
13. Gregoratos G., Abrams J., Epstein A.E., Freedman R.A., Hayes D.L., Hlatky M.A., Kerber R.E., Naccarelli G.V., Schoenfeld M.H., Silka M.J., Winters S.L., Gibbons R.J., Antman E.M., Alpert J.S., Gregoratos G., Hiratzka L.F., Faxon D.P., Jacobs A.K., Fuster V., and Smith Jr. S.C. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 (2002) 2145-2161
14. Yu C.M., Bleeker G.B., Fung J.W., Schalij M.J., Zhang Q., van der Wall E.E., Chan Y.S., Kong S.L., and Bax J.J. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 112 (2005) 1580-1586
15. Bleeker G.B., Bax J.J., Fung J.W., van der Wall E.E., Zhang Q., Schalij M.J., Chan J.Y., and Yu C.M. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 97 (2006) 260-263
16. Mollema S.A., Bleeker G.B., van der Wall E.E., Schalij M.J., and Bax J.J. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure. Am J Cardiol 100 (2007) 1665-1670
17. Ypenburg C., Schalij M.J., Bleeker G.B., Steendijk P., Boersma E., Dibbets-Schneider P., Stokkel M.P., van der Wall E.E., and Bax J.J. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 28 (2007) 33-41
18. Richardson M., Freemantle N., Calvert M.J., Cleland J.G., and Tavazzi L. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. Eur Heart J 28 (2007) 1827-1834
19. Diaz-Infante E., Mont L., Leal J., Garcia-Bolao I., Fernandez-Lozano I., Hernandez-Madrid A., Perez-Castellano N., Sitges M., Pavon-Jimenez R., Barba J., Cavero M.A., Moya J.L., Perez-Isla L., and Brugada J. Predictors of lack of response to resynchronization therapy. Am J Cardiol 95 (2005) 1436-1440
20. Bax J.J., Abraham T., Barold S.S., Breithardt O.A., Fung J.W., Garrigue S., Gorcsan III J., Hayes D.L., Kass D.A., Knuuti J., Leclercq C., Linde C., Mark D.B., Monaghan M.J., Nihoyannopoulos P., Schalij M.J., Stellbrink C., and Yu C.M. Cardiac resynchronization therapy: part 1-issues before device implantation. J Am Coll Cardiol 46 (2005) 2153-2167
21. Molhoek S.G., Bax J.J., Bleeker G.B., Boersma E., van Erven L., Steendijk P., van der Wall E.E., and Schalij M.J. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 94 (2004) 1506-1509
22. Gasparini M., Auricchio A., Regoli F., Fantoni C., Kawabata M., Galimberti P., Pini D., Ceriotti C., Gronda E., Klersy C., Fratini S., and Klein H.H. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48 (2006) 734-743
23. Bleeker G.B., Schalij M.J., van der Wall E.E., and Bax J.J. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 17 (2006) 899-901
24. Adelstein E.C., and Saba S. Scar burden by myocardial perfusion imaging predicts echocardiographic response to cardiac resynchronization therapy in ischemic cardiomyopathy. Am Heart J 153 (2007) 105-112
25. van Bommel R.J., Bax J.J., Abraham W.T., Chung E.S., Pires L.A., Tavazzi L., Zimetbaum P.J., Gerritse B., Kristiansen N., and Ghio S. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30 (2009) 2470-2477
26. Ypenburg C., van Bommel R.J., Delgado V., Mollema S.A., Bleeker G.B., Boersma E., Schalij M.J., and Bax J.J. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 52 (2008) 1402-1409
27. Murphy R.T., Sigurdsson G., Mulamalla S., Agler D., Popovic Z.B., Starling R.C., Wilkoff B.L., Thomas J.D., and Grimm R.A. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 97 (2006) 1615-1621
28. Fung J.W., Lam Y.Y., Zhang Q., Yip G.W., Chan W.W., Chan G.C., Chan J.Y., and Yu C.M. Effect of left ventricular lead concordance to the delayed contraction segment on echocardiographic and clinical outcomes after cardiac resynchronization therapy. J Cardiovasc Electrophysiol 20 (2009) 530-535